Pedometers for the Enhancement of Post Cesarean Mobility

Using Pedometers for the Enhancement of Post Caesarean Mobility in High Risk Patients Using a Personalized Repeated Feedback Approach - a Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03724760

Enrollment

291

Registered

2018-10-30

Start date

2018-12-03

Completion date

2019-07-30

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mobility Limitation

Brief summary

This is a randomized controlled trial, planned to study the effects of pedometers (digital step counters) on patient mobility following cesarean delivery. The investigators plan to randomize patients at high risk for thromboembolic events to participants with a personalized repeated feedback approach based on pedometer results, versus participants with no feedback to pedometer results.

Interventions

OTHERpersonalized repeated feedback approach

Feedback on number of steps taken by patint, as recorded by pedometers, provided by research team

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients following cesarean delivery * Consent to participation * No medical recommendation for bed rest and limited mobility * Meet any of the following criteria for high risk for thromboembolic complications - preeclampsia, chronic disease (reumatic, inflammatory bowel disease), obese, smoker \> 10 cigaretts a day, age \>35, substantial limb varicose, multiple gestation, multiparity (\> deliveries), emergent surgery, thrombophilia.

Exclusion criteria

* Refusal to participate * Medical recommendation to limit mobility

Design outcomes

Primary

Measure	Time frame	Description
Number of steps	48 hours	Number of steps taken by patient as recirded by pedometer

Secondary

Measure	Time frame	Description
Number of participants with a postpartum complication composite	48 hours	Composite of postpartum complications, including infectious (endometritis, wound), blood product transfusion
Number of analgesic doses	48 hours	Number of doses of analgesics consumed by patient
Length of hospitalization	From 72 hours to one week	Duration of postpartum hospitalization
Number of thromboembolic events	Six weeks	Thromboembolic events during the post partum period, including deep vein thrombosis and pulmonary emboli

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026